# MESALAMINE
> **ANDA208362** · Abbreviated New Drug Application (Generic) · Sponsor: AMRING PHARMS · Approved 2019-06-21
## Drug
- **FDA Application Number:** ANDA208362
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MESALAMINE
- **Generic name:** MESALAMINE
- **Active ingredients:** MESALAMINE
- **Dosage form:** SUPPOSITORY
- **Route:** RECTAL
- **Marketing status:** Prescription
- **Sponsor:** AMRING PHARMS
- **Manufacturer:** Amring Pharmaceuticals Inc.
- **First approval:** 2019-06-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208362)
---
*MORVS · CC0 1.0*